| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.31 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |